Sarepta Therapeutics
SRPT
SRPT
453 hedge funds and large institutions have $10.7B invested in Sarepta Therapeutics in 2024 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 170 increasing their positions, 155 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $14B → $10.7B (-$3.32B)
31% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 83
50% less funds holding in top 10
Funds holding in top 10: 16 → 8 (-8)
Holders
453
Holding in Top 10
8
Calls
$278M
Puts
$221M
Top Buyers
| 1 | +$242M | |
| 2 | +$87.3M | |
| 3 | +$83.1M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$78.1M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$67.8M |
Top Sellers
| 1 | -$222M | |
| 2 | -$209M | |
| 3 | -$150M | |
| 4 |
Jane Street
New York
|
-$103M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$78M |